Your browser doesn't support javascript.
loading
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging.
Marsden, Teresa; McCartan, Neil; Hadley, Joanna; Tuck, Steve; Brown, Louise; Haire, Anna J; Moss, Charlotte L; Green, Saran; Van Hemelrijck, Mieke; Coolen, Ton; Santaolalla, Aida; Isaac, Elizabeth; Brembilla, Giorgio; Kopcke, Douglas; Giganti, Francesco; Sidhu, Harbir; Punwani, Shonit; Emberton, Mark; Moore, Caroline M.
Afiliação
  • Marsden T; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: teresa.marsden@ucl.ac.uk.
  • McCartan N; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Hadley J; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Tuck S; ReIMAGINE Consortium Patient Representative.
  • Brown L; MRC Clinical Trials Unit, University College London, London, UK.
  • Haire AJ; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Green S; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Coolen T; London Institute for Mathematical Sciences, London, UK.
  • Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London School of Medicine, London, UK.
  • Isaac E; Centre for Medical Imaging, University College London, London, UK.
  • Brembilla G; Centre for Medical Imaging, University College London, London, UK.
  • Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Giganti F; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Sidhu H; Centre for Medical Imaging, University College London, London, UK.
  • Punwani S; Centre for Medical Imaging, University College London, London, UK.
  • Emberton M; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Moore CM; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Eur Urol Focus ; 7(3): 503-505, 2021 05.
Article em En | MEDLINE | ID: mdl-33896710
ABSTRACT
ReIMAGINE Screening is a single-centre study assessing the feasibility of biparametric magnetic resonance imaging as a screening tool for prostate cancer. The study outcomes will take us a step towards more accurate and less harmful prostate cancer screening.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2021 Tipo de documento: Article
...